Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00146848 · ClinicalTrials.gov registry record · Phase 4
PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy
A Phase 4 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,742
- Enrollment target
NCT00146848 is a Phase 4 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,742 participants.
The verdict
NCT00146848, a Phase 4 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,742 participants
- Enrollment target
Study Summary
This study will look at different pacing modes (how a device is programmed to pace one's heart), and how these modes may assist in one's daily activities and how one is feeling.
Interventions
- DEVICE Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,742 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00146848
The ClinicalTrials.gov registry entry for NCT00146848 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,742 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices is the first listed.
NCT00146848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00146848 about?
NCT00146848 is a clinical study titled "PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy". This study will look at different pacing modes (how a device is programmed to pace one's heart), and how these modes may assist in one's daily activities and how one is feeling.
What is the current status of trial NCT00146848?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,742 participants. The study started on 2004-12. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00146848?
The interventions under investigation include: Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D devices (DEVICE).
Who is sponsoring clinical trial NCT00146848?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.